FR2260M - Dérivés de la 16 alpha-chloroprednisolone et compositions thérapeutiques en contenant. - Google Patents

Dérivés de la 16 alpha-chloroprednisolone et compositions thérapeutiques en contenant.

Info

Publication number
FR2260M
FR2260M FR921196A FR921196A FR2260M FR 2260 M FR2260 M FR 2260M FR 921196 A FR921196 A FR 921196A FR 921196 A FR921196 A FR 921196A FR 2260 M FR2260 M FR 2260M
Authority
FR
France
Prior art keywords
alpha
compositions containing
therapeutic compositions
chloroprednisolone
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR921196A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US144830A external-priority patent/US3137712A/en
Application filed by Upjohn Co filed Critical Upjohn Co
Priority to FR921196A priority Critical patent/FR2260M/fr
Application granted granted Critical
Publication of FR2260M publication Critical patent/FR2260M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR921196A 1961-10-13 1963-01-11 Dérivés de la 16 alpha-chloroprednisolone et compositions thérapeutiques en contenant. Active FR2260M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR921196A FR2260M (fr) 1961-10-13 1963-01-11 Dérivés de la 16 alpha-chloroprednisolone et compositions thérapeutiques en contenant.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US144830A US3137712A (en) 1961-10-13 1961-10-13 16alpha-chloro-1, 4-pregnadienes
US20240362A 1962-06-14 1962-06-14
FR912163A FR1509904A (fr) 1961-10-13 1962-10-12 Nouveaux 16 alpha-chloro-11 bêta-hydroxy stéroïdes et procédés pour leur préparation
FR921196A FR2260M (fr) 1961-10-13 1963-01-11 Dérivés de la 16 alpha-chloroprednisolone et compositions thérapeutiques en contenant.

Publications (1)

Publication Number Publication Date
FR2260M true FR2260M (fr) 1964-01-06

Family

ID=26842402

Family Applications (1)

Application Number Title Priority Date Filing Date
FR921196A Active FR2260M (fr) 1961-10-13 1963-01-11 Dérivés de la 16 alpha-chloroprednisolone et compositions thérapeutiques en contenant.

Country Status (2)

Country Link
FR (1) FR2260M (fr)
GB (3) GB1026502A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19715594A1 (de) 1997-04-15 1998-10-22 Bayer Ag Analgetika-Kombination

Also Published As

Publication number Publication date
GB1026503A (en) 1966-04-20
GB1026501A (en) 1966-04-20
GB1026502A (en) 1966-04-20

Similar Documents

Publication Publication Date Title
BE615975A (fr) Compositions thérapeutiques contenant de la sitostérine et leur préparation
BE622943A (fr) Compositions thérapeutiques, contenant des dérivés d'émétine.
FR2517M (fr) Compositions pharmaceutiques contenant des propanolamines.
FR2075M (fr) Nouveaux dérivés de la 6-méthyl- et de la 1,6-diméthyl-ergoline i.
FR3383M (fr) Dérivés du camphene-phénol et compositions pharmaceutiques les contenant.
FR2260M (fr) Dérivés de la 16 alpha-chloroprednisolone et compositions thérapeutiques en contenant.
FR1347153A (fr) Compositions d'enduisage
FR3173M (fr) Dérivés thérapeutiques d'aralcoyl-2-mercapto-benzazoles.
FR1300758A (fr) Nouveaux agents anticryptogamiques et leurs procédés de préparation et d'application
FR1288907A (fr) Dérivés de cystéine et leur préparation
FR3270M (fr) Nouveaux dérivés de l'imidazole et compositions les contenant.
BE619267A (fr) Dérivés d'algines dépolymérisées.
BE615088A (fr) Composition thérapeutique parfumée
FR2985M (fr) Compositions pharmaceutiques contenant des dérivés de l'indole.
BE622395A (fr) Dérivés d'ajmaline
FR1571M (fr) Nouveaux dérivés de coumarine substituée et compositions pharmaceutiques en contenant.
FR1292270A (fr) Préparation de 3. 4-dihydro-isoquinoléines
FR1318976A (fr) Compositions d'encausticage
BE617913A (fr) Préparation de 2,6-dialcoyl-phénols
BE615452A (fr) Nouveaux médicaments dérivés de l'oxazolidinone-2
FR1063M (fr) Compositions pharmaceutiques contenant une association de diphényl-1,1 hexaméthylene-3-iminopropane et de sorbitol.
FR2395M (fr) Compositions thérapeutiques contenant du 3,5-diméthylisoxazole.
FR1893M (fr) Dérivés de la 4-quinazolone et de la 2,4-quinazolinedione utilisables comme médicaments anti-hypertensifs.
FR2620M (fr) Nouvel antibiotique et compositions le contenant.
BE617616A (fr) Dérivés de polyhydrophénanthrènes, compositions pharmaceutiques en contenant et leur préparation.